Home/Autonomous Therapeutics/Ariel Weinberger, PhD

AW

Ariel Weinberger, PhD

CEO & Founder

Autonomous Therapeutics

Therapeutic Areas

Infectious Disease Oncology

Autonomous Therapeutics Pipeline

Drug	Indication	Phase
Encrypted RNA™ Programs	Oncology (e.g., Colon Cancer)	Preclinical
TIPs Programs	Infectious Diseases (e.g., Influenza, SARS-CoV-2)	Preclinical

Leadership Team at Autonomous Therapeutics

Timothy Notton, PhD

Chief Scientific Officer

Leor Weinberger, PhD

President of R&D & Co-founder

View full Autonomous Therapeutics profile